Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-09

Clinical Trial Update: Granisetron in Diabetic Parturients Decrease Spinal Induced Hypotension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating granisetron to decrease spinal-induced hypotension in diabetic parturients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Granisetron (granisetron)

Snippet

Sponsor: Suez Canal University | Conditions: Spinal-induced Hypotension | Phase 4 | Status: COMPLETED